Source:http://linkedlifedata.com/resource/pubmed/id/15566800
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-11-29
|
pubmed:abstractText |
The clinical manifestations of human parvovirus B19 infection are often similar to those induced as the result of infection by other infectious agents such as rubella and some bacteria. Although diagnosis of B19 infection is feasible by detection of specific antibodies, the tests require viraemic serum as a source of antigen. This inevitably leads to problems of reproducibility and dependence upon appropriate high quality clinical material.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0928-0197
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
181-90
|
pubmed:year |
1995
|
pubmed:articleTitle |
Development of an IgM capture assay for the diagnosis of B19 parvovirus infection using recombinant baculoviruses expressing VP1 or VP2 antigens.
|
pubmed:affiliation |
Regional Virus Laboratory, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BN, Northern Ireland, United Kingdom.
|
pubmed:publicationType |
Journal Article
|